DNA test for cervical cancer screening
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study tests a new way to screen for cervical cancer by looking for certain DNA changes in a swab sample from the cervix. It may help find cancer or pre-cancer earlier, when it is easier to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have your uterus and cervix (the lower part of the womb) intact.
- You must give your permission to take part.
- You must be able to have follow-up check-ups or results tracked.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how changes in DNA (called methylation) may be linked to a higher chance of developing cervical cancer. By studying blood and tissue samples from people with abnormal screening results, researchers hope to find better ways to predict risk and detect cervical cancer earlier.
This study tests a simple cervical swab (like a Pap smear) to see if it can help find or monitor endometrial cancer or precancerous changes. It aims to find a less invasive way to screen and follow up on this condition.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study is testing a new, non-invasive way to screen for cervical cancer using light-based detection and epigenetic analysis. It may help find high-risk changes earlier and more accurately than current methods.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.